Adrenal Diabetes Metabolism Obesity Cardiovascular Bone Endocrine-Disrupting Chemicals Endocrine-Related Cancer Neuroendocrinology Reproduction Steroid and Steroidogenesis Thyroid
ACROSTUDY data indicates that growth hormone blocker, pegvisomant, is safe and effective for long-term use in acromegaly patients. The full multi-centre report is published in the European Journal of Endocrinology.
According to a Danish study, published in Clinical Endocrinology, the use of melatonin to help sleep is not only safe for people with metabolic diseases but may even have a beneficial effect on BMI and insulin sensitivity.
Side-specific movement problems caused by traumatic brain injury may be improved by blocking pituitary hormones, ß-endorphin and vasopressin, according to a Swedish study published in eLife.
Diabetes patients with cognitive problems, and taking dipeptidyl peptidase-4 (DPP-4) inhibitors, were found to have slower cognitive decline and less amyloid beta in their brains. These findings, published in Neurology, suggest that DPP-4 inhibitors may have a protective effect for patients with diabetes and dementia.
A recent study, published in the Journal of Women & Aging, suggests women chatting with their female friends have lower cortisol levels and that this is a stress-busting activity that fits within the 'tend-and-befriend' theory.
According to a German study, published in Cell Metabolism, raised leptin levels cause hypervascularisation in the hypothalamus, via an astrocytic mechanism, that leads to hypertension. This mouse study highlights a novel role for astrocytes in blood pressure control.
